综述:经颈静脉肝内门体分流术后肝性脑病——当前认知与未来展望
本文为叙述性综述,检索肝硬化患者经颈静脉肝内门体分流术(TIPSS)后肝性脑病(post-TIPSS HE)的文献。post-TIPSS HE发生率高达54.5%,早期复发者预后差;危险因素包括肝功能评分、轻微HE所致认知障碍、肌少症及质子泵抑制剂等;利福昔明与较小支架覆膜的新数据可能改善预防。
要点
- post-TIPSS HE发生率高达54.5%,尤其早期复发性HE与不良预后相关。
- 危险因素包括MELD/Child-Pugh评分、轻微HE所致认知障碍、肌少症及质子泵抑制剂等。
- 利福昔明与较小支架覆膜的新数据可能改善post-TIPSS HE的预防。
核心结论
- 精心选择TIPSS候选者是降低post-TIPSS HE风险的关键。
- 本叙述性综述简要概述了post-TIPSS HE当前的流行病学、危险因素及治疗选择。
研究设计与样本
- 叙述性综述,检索肝硬化患者post-TIPSS HE相关文献。
主要发现
- post-TIPSS HE发生率高达54.5%,尤其早期复发性HE与不良预后相关。
- 已识别的危险因素包括反映肝功能的指标(MELD评分/Child-Pugh评分)、轻微HE所致认知障碍,以及肌少症和质子泵抑制剂等肝外因素。
- 利福昔明与较小支架覆膜的新数据出现,可能改善post-TIPSS HE的预防。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In light of the global rise in the burden of chronic liver diseases and liver cirrhosis, the number of patients suffering from decompensation events is expected to increase. Transjugular intrahepatic portosystemic shunts (TIPSS) provide effective long-term symptom control and may prolong transplant-free survival in portal hypertension-driven recurrent ascites and variceal bleeding. New-onset or recurrent hepatic encephalopathy (HE) after TIPSS insertion (post-TIPSS HE) represents the most severe post-interventional complication. AIMS: To provide insight into the epidemiology and risk factors for post-TIPSS HE and scrutinize the current state of the art in treatment and drug therapy options. METHODS: We conducted a literature search on post-TIPSS HE in patients with liver cirrhosis. RESULTS: Post-TIPSS HE occurs in up to 54.5% of cases and particularly early recurrent HE is associated with a dismal prognosis. In recent years, several risk factors for the development of post-TIPSS HE have been identified. These include not only parameters reflecting liver function (model for end-stage liver disease score/Child-Pugh score) as well as cognitive dysfunction caused by minimal HE but also extrahepatic factors such as sarcopenia and common medications such as proton pump inhibitors. In addition, new data on the benefit of rifaximin and of smaller stent grafts emerged and may improve the prevention of post-TIPSS HE. CONCLUSIONS: Careful selection of TIPSS candidates is of utmost importance to reduce the risk of post-TIPSS HE. In this narrative review, we provide a concise overview of the current epidemiology and risk factors of the treatment options for post-TIPSS HE.
引用
- Gairing SJ, Müller L, Kloeckner R, et al. Review article: post-TIPSS hepatic encephalopathy-current knowledge and future perspectives. Aliment Pharmacol Ther. 2022. PMID: 35181894. doi:10.1111/apt.16825
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。